0000899243-21-026088.txt : 20210625 0000899243-21-026088.hdr.sgml : 20210625 20210625200045 ACCESSION NUMBER: 0000899243-21-026088 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210624 FILED AS OF DATE: 20210625 DATE AS OF CHANGE: 20210625 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lager Joanne Jenkins CENTRAL INDEX KEY: 0001816215 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39401 FILM NUMBER: 211049646 MAIL ADDRESS: STREET 1: C/O ITEOS THERAPEUTICS, INC. STREET 2: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: iTeos Therapeutics, Inc. CENTRAL INDEX KEY: 0001808865 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 857-204-4583 MAIL ADDRESS: STREET 1: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-24 0 0001808865 iTeos Therapeutics, Inc. ITOS 0001816215 Lager Joanne Jenkins C/O ITEOS THERAPEUTICS, INC. 139 MAIN STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Medical Officer Stock Option (Right to Buy) 23.19 2021-06-24 4 A 0 24000 0.00 A 2031-06-24 Common Stock 24000 24000 D This stock option shall vest over 4 years, with 25% vesting on June 24, 2022 and thereafter in equal monthly installments over the next 36 months subject to the Reporting Person's continued service to the Issuer. /s/ Michel Detheux, as Attorney-in-Fact 2021-06-24